Brown Advisory Inc. cut its holdings in shares of Davita Inc (NYSE:DVA) by 28.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 71,611 shares of the company’s stock after selling 28,242 shares during the period. Brown Advisory Inc.’s holdings in Davita were worth $5,173,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of DVA. Schroder Investment Management Group lifted its position in Davita by 769.0% during the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock valued at $25,387,000 after purchasing an additional 384,224 shares during the period. Locust Wood Capital Advisers LLC acquired a new position in Davita during the fourth quarter valued at $20,657,000. Canada Pension Plan Investment Board lifted its position in Davita by 14.7% during the third quarter. Canada Pension Plan Investment Board now owns 444,358 shares of the company’s stock valued at $26,390,000 after purchasing an additional 56,988 shares during the period. State of Wisconsin Investment Board lifted its position in Davita by 50.6% during the fourth quarter. State of Wisconsin Investment Board now owns 127,470 shares of the company’s stock valued at $9,210,000 after purchasing an additional 42,815 shares during the period. Finally, Teacher Retirement System of Texas acquired a new position in Davita during the fourth quarter valued at $3,043,000. Institutional investors own 82.88% of the company’s stock.
DVA has been the subject of a number of research reports. Royal Bank of Canada decreased their target price on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating for the company in a research report on Wednesday, November 8th. Bank of America decreased their price objective on shares of Davita from $75.00 to $66.00 and set a “neutral” rating for the company in a research report on Wednesday, November 8th. Robert W. Baird reiterated a “hold” rating and issued a $63.00 price objective on shares of Davita in a research report on Friday, November 10th. KeyCorp reiterated a “hold” rating on shares of Davita in a research report on Monday, November 13th. Finally, Raymond James Financial upgraded shares of Davita from an “outperform” rating to a “strong-buy” rating and upped their price objective for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th. Two analysts have rated the stock with a sell rating, five have issued a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the stock. Davita presently has a consensus rating of “Hold” and an average target price of $79.30.
Davita (NYSE:DVA) last released its earnings results on Tuesday, February 13th. The company reported $0.92 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.02). The company had revenue of $2.78 billion for the quarter, compared to analysts’ expectations of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same period in the prior year, the firm earned $0.98 EPS. sell-side analysts expect that Davita Inc will post 4.15 EPS for the current year.
In other news, insider James K. Hilger sold 3,572 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the sale, the insider now owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Charles Berg sold 7,048 shares of the business’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $69.24, for a total transaction of $488,003.52. Following the sale, the insider now directly owns 5,359 shares of the company’s stock, valued at approximately $371,057.16. The disclosure for this sale can be found here. Insiders have sold 121,509 shares of company stock valued at $8,310,388 in the last three months. Corporate insiders own 2.00% of the company’s stock.
WARNING: This news story was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3227372/brown-advisory-inc-decreases-position-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.